Weisshaar, Elke http://orcid.org/0000-0002-7016-0224
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Accepted: 1 September 2024
First Online: 19 September 2024
Declarations
:
: Open Access funding enabled and organized by Projekt DEAL. No support was obtained from pharmaceutical companies, in either the conceptualization or preparation of this manuscript.
: Elke Weisshaar is an active member of the European and German guideline group on CHE and co-author of the European and German guidelines on HE. The content of this review reflects her active role in writing texts for these two guidelines. Elke Weisshaar treats HE patients sent by the German (Governmental) Statutory Accident Insurance. She initiated and leads a cohort study on optimized diagnostics of eczema-psoriasis of the hands that is supported by the German (Governmental) Statutory Accident Insurance, and serves as a Vice President and board member of the German Society for Occupational Dermatology (ABD). Elke Weisshaar is also Treasurer of the European Society of Contact Dermatitis; has participated in clinical trials on itch and prurigo for Menlo, Kiniksa, TREVI, and Galderma; and has been a consultant for Galderma, Sanofi, and LEO Pharmaceuticals.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: EW was the sole author of this manuscript.